Specific inhibition of hypoxia-inducible factor (HIF)-1α activation and of vascular endothelial growth factor (VEGF) production by flavonoids

被引:47
作者
Hasebe, Y
Egawa, K
Yamazaki, Y
Kunimoto, S
Hirai, Y
Ida, Y
Nose, K
机构
[1] Showa Univ Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Tokyo 1428555, Japan
[2] Showa Univ Pharmaceut Sci, Dept Pharmacognosy & Phytochem, Shinagawa Ku, Tokyo 1428555, Japan
[3] Inst Microbial Chem, Shinagawa Ku, Tokyo 1410021, Japan
关键词
hypoxia response element; flavonoid; reporter assay; angiogenesis; vascular endothelial growth factor (VEGF); p53;
D O I
10.1248/bpb.26.1379
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Screening using a reporter under the control of the hypoxia-response element (HRE) identified several flavonoids and homoisollavonoids that inhibit the activation of HRE under hypoxic conditions. Among various compounds, isorhamnetin, luteolin, quercetin, and methyl ophiopogonanone B (MOB) were effective at 3 to 9 mug/ml in inhibiting the reporter activity. The expression of vascular endothelial growth factor (VEGF) mRNA during hypoxia was also inhibited by MOB in HepG2 cells, but the effective doses were 10 to 20 mug/ml. MOB caused destabilization of hypoxia-inducible factor (HIF)-2alpha, as revealed by Western blotting, that was dependent on proteasome activity and the tumor suppressor, p53. The tubular formation and migration of human umbilical vein endothelial cells was also inhibited by MOB. MOB is expected to act as an inhibitor of angiogenesis.
引用
收藏
页码:1379 / 1383
页数:5
相关论文
共 36 条
[1]  
AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
[2]  
ASAMI A, 1991, CHEM PHARM BULL, V39, P2053, DOI 10.1248/cpb.39.2053
[3]  
BECK I, 1993, BLOOD, V82, P704
[4]  
Egawa K, 1998, BIOL PHARM BULL, V21, P899
[5]  
Egawa K, 2000, BIOL PHARM BULL, V23, P1036
[6]  
Fong TAT, 1999, CANCER RES, V59, P99
[7]  
FORSYTHE JA, 1996, MOL CELL BIOL, V16, P4605
[8]   Two stages of cancer prevention with green tea [J].
Fujiki, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (11) :589-597
[9]  
Hajitou A, 2001, CANCER RES, V61, P3450
[10]   The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells [J].
Hajitou, A ;
Grignet-Debrus, C ;
Devy, L ;
Berndt, S ;
Blacher, S ;
Deroanne, CF ;
Bajou, K ;
Fong, T ;
Chiang, YW ;
Foidart, JM ;
Noël, A .
FASEB JOURNAL, 2002, 16 (11) :1802-+